Share buy-back programs

Stock dividends, compensation plans & reducing issued capital

Buy-back programs

It is necessary for DSM to undertake regular share buy-back programs to cover its commitment to shareholders wishing to receive their dividend in the form of ordinary shares, as well as to fulfill its obligations under share-based compensation plans.

DSM obtains approval for the company to repurchase its own shares each year at the Annual General Meeting of Shareholders. Each year we also obtain approval to reduce the company's issued capital by cancellation of its shares up to a maximum of the number that is, or will be bought by, the company.

2020: 200,000 shares

August 2020

DSM repurchased a total of 200,000 shares for a combined consideration of €26 million in accordance with the repurchase program announced on 7 August 2020. This Daily Transaction Details Share Repurchase Program spreadsheet was updated weekly during the course of the program.

Press releases

Recent programs

2020: 1,400,000 shares

March 2020

DSM repurchased a total of 1,400,000 shares for a combined consideration of €137.8 million in accordance with the repurchase program announced on 2 March 20201. This Daily Transaction Details Share Repurchase Program spreadsheet was updated weekly during the course of the program.

2019 - 2020: 9,238,971 shares

Apr 2019 - Feb 2020

DSM repurchased a total of 9,238,971 shares for a combined consideration of €1.01 billion in accordance with the repurchase program announced on 14 March 20191. This Daily Transaction Details Share Repurchase Program spreadsheet was updated weekly during the course of the program.

2018: 1,100,000 shares

August to October

DSM repurchased a total of 1,100,000 shares for a combined consideration of €98.9 million in accordance with the repurchase program announced on 13 August 2018. This Daily Transaction Details Share Repurchase Program spreadsheet was updated weekly during the course of the program.

2018: 1,600,000 shares

March to April & May to June

DSM repurchased a total of 1,600,000 shares for a combined consideration of €136.7 million in accordance with the repurchase program announced on 19 March 2018. This Daily Transaction Details Share Repurchase Program spreadsheet was updated weekly during the course of the program.

2017: 1,600,000 shares

August - November

DSM repurchased a total of 1,600,000 shares for a combined consideration of €109.3 million in accordance with the repurchase program announced on 14 August 2017. This Daily Transaction Details Share Repurchase Program spreadsheet was updated weekly during the course of the buy-back program.

2017: 2,900,000 shares

March - July

DSM repurchased a total of 2,900,000 shares for a combined consideration of €187.2 million in accordance with the repurchase program announced on 13 March 2017. This Daily transaction details Share Repurchase Program spreadsheet was updated weekly during the course of the buy-back program.

2016: 1,700,000 shares

November - December

DSM repurchased a total of 1,700,000 shares for a combined consideration of €96.0 million in accordance with the repurchase program announced on 4 November 2016. This Daily Transaction Details Share Repurchase Program spreadsheet was updated weekly during the course of the buy-back program.

2016: 3,500,000 shares

February - July

DSM repurchased a total of 3,500,000 shares for a combined consideration of €176.8 million in accordance with the repurchase program announced on 22 February 2016. DSM informed the market about the program's progress via weekly press releases.

2015: 2,300,000 shares

May - July

DSM repurchased a total of 2,300,000 shares for a combined consideration of €122.5 million in accordance with the repurchase program announced on 14 May 2015. DSM informed the market about the program's progress via weekly press releases.

1) Given Covid-19 and the acquisition of Erber Group, DSM canceled the remainder of the €1 billion share buy-back program in June 2020 having repurchased 6,638,971 shares during 2019 (5.4m shares/€600m) and January - February 2020 for a total of €745 million.

Statement pursuant to art. 5:25a of the Dutch Financial Supervision Act

DSM declares that the Netherlands is its "Home Member State", as required by article 5:25a (2) of the Dutch Financial Supervision Act. This article obliges all listed companies to publicly announce which country is their "home member state" (as referred to in article 5:25a(1) sub c of the Dutch Financial Supervision Act) for purposes of regulation of their disclosure obligations under the EU Transparency Directive. Pursuant to section 5:25a of the Dutch Financial Supervision Act, Royal DSM has notified the Dutch Authority for the Financial Markets (AFM).

Read more

This site uses cookies to optimize your user experience.

Read more